Different treatment interventions affect plasma NT-ProBNP levels and early exercise tolerance in patients with acute ST-segment elevation myocardial infarction.

about

Different treatment interventions affect plasma NT-ProBNP levels and early exercise tolerance in patients with acute ST-segment elevation myocardial infarction.

Item

http://www.wikidata.org/entity/Q48603602

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Different treatment interventi ...... evation myocardial infarction.

@en

Different treatment interventi ...... evation myocardial infarction.

@nl

type

Item

label

Different treatment interventi ...... evation myocardial infarction.

@en

Different treatment interventi ...... evation myocardial infarction.

@nl

prefLabel

Different treatment interventi ...... evation myocardial infarction.

@en

Different treatment interventi ...... evation myocardial infarction.

@nl

P1476

Different treatment interventi ...... evation myocardial infarction.

@en

P2093

Bin Li

http://www.w3.org/2001/XMLSchema#string

Hong Jiang

http://www.w3.org/2001/XMLSchema#string

Rui Zhu

http://www.w3.org/2001/XMLSchema#string

Xiao-lin Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Serum cardiac markers in patients with acute myocardial infarction: oxidative stress, C-reactive protein and N-terminal probrain natriuretic Peptide.

2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study.

Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial.

Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.

Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry).

NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers.

Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure.

N-terminal pro-brain natriuretic peptide in the elderly with myocardial infarction.

Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.

P304

58-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2012.03.2537

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22437216

http://www.w3.org/2001/XMLSchema#string